News Focus
News Focus
icon url

DewDiligence

09/28/15 5:39 PM

#195412 RE: DewDiligence #195409

Curious that ESPR’s PR has no details wrt combination trials with Zetia. Someone on the CC asked about Zetia, but the answer dodged the question completely.

All told, this is not a good CC for ESPR, IMO.
icon url

DewDiligence

09/29/15 10:02 AM

#195431 RE: DewDiligence #195409

ESPR -35% (-82% from 2015 high) on fallout from yesterday’s PR and CC.

Looks like #msg-115686242 was a good call.